(2011) (OP0288) TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS FOR 5 YEARS WITH DENOSUMAB: TWO-YEAR RESULTS FROM THE FREEDOM TRIAL EXTENSION

R. Chapurlat 1 , H.G. Bone 2 , M.L. Brandi 3 , J.P. Brown 4 , E. Czerwinski 5 , N.S. Daizadeh 6 , A. Grauer 6 , M.-A. Krieg 7 , C. Libanati 6 , Z. Man 8 , D. Mellstrom 9 , S. Radominski 10 , J.-Y. Reginster 11 , H. Resch 12 , J.A. Roman 13 , C. Roux 14 , S.R. Cummings 15 , S. Papapoulos 16 1 Hopital Edouard Herriot, Lyon, France; 2 Michigan Bone & Mineral Clinic, Detroit, United States; 3 Univ. of Florence, Azienda Ospedaliera Careggi, Florence, Italy; 4 Laval Univ. and CHUQ, Quebec City, Canada; 5 Krakow Medical Centre, Krakow, Poland; 6 Amgen Inc., Thousand Oaks, United States; 7 Centre Hospitalier Universitaire Vaudois, CHUV, Lausanne, Switzerland; 8 Centro TIEMPO, Buenos Aires, Argentina; 9 Center for Bone Research at the Sahlgrenska Academy, Goteburg, Sweden; 10 Hospital de Clinicas da Universidade Federal do Parana, Curitiba, Brazil; 11 Univ. of Liege, Belgium; 12 Krankenhaus der Barmherzigen Schwestern II. Med. Abteilung, Wien, Austria; 13 Hospital Dr Peset, Valencia, Spain; 14 Hopital Cochin CEMO, Paris, France; 15 San Francisco Coordinating Center, CPMC Res. Inst., San Francisco, United States; 16 Leiden Univ. Medical Center, Leiden, Netherlands